Intervention Review

Prophylactic methylxanthine for prevention of apnoea in preterm infants

  1. David J Henderson-Smart1,
  2. Antonio G De Paoli2

Editorial Group: Cochrane Neonatal Group

Published Online: 8 DEC 2010

Assessed as up-to-date: 29 SEP 2010

DOI: 10.1002/14651858.CD000432.pub2

How to Cite

Henderson-Smart DJ, De Paoli AG. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD000432. DOI: 10.1002/14651858.CD000432.pub2.

Author Information

  1. 1

    Faculty of Medicine, University of Sydney, (Deceased) Central Clinical School, Sydney, Australia

  2. 2

    Royal Hobart Hospital, Department of Paediatrics, Hobart, Tasmania, Australia

*Diane Haughton, Department of Pediatrics and Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, CRL, Room B102, Hamilton, Ontario, L8S 4K1, Canada.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 DEC 2010


Cited in:


This article has been cited by:

  1. 1
    Amir Mohammad Armanian, Zohreh Badiee, Raha Afghari, Nima Salehimehr, Akbar Hassanzade, Soghra Sheikhzadeh, Maryam Sharif Tehrani, Gohar Rezvan, Prophylactic Aminophylline for Prevention of Apnea at Higher-Risk Preterm Neonates, Iranian Red Crescent Medical Journal, 2014, 16, 8